ENEVOLV, INC.
Cambridge, US · Founded 2011
Biotech
Founders & leadership
JK
Jay KonieczkaNamed on SEC filing
MF
Marco FarsheedNamed on SEC filing
RM
Ron MeeusenNamed on SEC filing
FI
Farren IsaacsNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$1.8M disclosed across 1 round · 2014
▶$1.8MraisedFeb 2014 · 13 investors · BiotechnologyRule 506(b)
▶$1.8MraisedFeb 2014 · 13 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jay KonieczkaExecutive Officer, Director
- Marco FarsheedExecutive Officer, Director
- Ron MeeusenDirector
- Farren IsaacsExecutive Officer, Director
- Offering amount
- $1.8M
- Amount sold
- $1.8M
- Proceeds to insiders
- $484.5K
- First sale
- Feb 2014
- Incorporated
- Corporation, Delaware, 2011
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 5 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Science Foundation | Phase I | 2017 | $225K |
| Defense Advanced Research Projects Agency (DARPA)Defense Advanced Research Projects Agency | Phase II | 2016 | $1.5M |
| National Science Foundation | Phase II | 2015 | $608.7K |
| Defense Advanced Research Projects Agency (DARPA)Defense Advanced Research Projects Agency | Phase ISTTR | 2015 | $150K |
| National Science Foundation | Phase I | 2013 | $150K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- How much funding has ENEVOLV, INC. raised?
- ENEVOLV, INC. has disclosed $1.8M raised across 1 round.
- Where is ENEVOLV, INC. headquartered?
- ENEVOLV, INC. is headquartered in Cambridge, US.